🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to speaking at The Festival of Genomics & BioData on the 4th-5th of October in Boston! Thanks to Front Line Genomics for the invite.😀 Check here for more info: hubs.la/Q01MkQpf0 #FOGBoston

Truly grateful to be selected as the inaugural 'CLEAR-AD' Diversity Scholar to rep Mayo Clinic. This The National Institute on Aging (NIA) U19 program, led by Nilufer Ertekin-Taner, MD, PhD, aims to establish #Alzheimers #precisionmedicine biomarkers and therapies. Excited for the future of using omics data to #ENDALZ!

#ACR23 American College of Rheumatology Lots of hard work from the #vasculitis team Mayo Clinic Mahmut Kaymakci, MD Max Guarda, MD Dr. Koster & Dr. C. Weyand lab Shozo Ohtsuki Jaeyun Sung, PhD 11 posters, 5 oral abstracts author/co-authored, with collaborations Despina Michailidou, MD, PhD & VCRC

End-of-summer photoshoot of our team Mayo Clinic: two post-docs, four grad/med students, and five nationalities 🌎 (USA, Korea, China, India, Canada). Our mission? Harnessing computational power to advance #PrecisionMedicine in autoimmunity, dementia, and critical illness. 💻🔬

Recently visited the Indiana Alzheimer's Disease Research Center to talk about computational blood biomarker discovery for #ALZ precision healthcare and medicine.🧠Huge thanks to the stellar Indiana Alzheimer's Disease Research Center team for having me! Andrew Saykin Jungsu Kim Kwangsik T. Nho Yunlong Liu Meichen Yu

Not in the club... "We... had looked forward to hearing excited responses from fellow mRNA researchers, but this never happened. We thought that presenting our work at meetings would be helpful to disseminate our results, but we were not invited to present."

Imagine gut microbiome testing as part of our routine health checks. Soon, we'll be able to non-invasively and longitudinally track health, just by screening for gut microbes in 💩. Presenting the 2nd iteration of our stool metagenome health indicator: biorxiv.org/content/10.110…

At #FOGBoston The Festival of Genomics & Biodata hearing about cutting-edge works in the #Genomics biotech industry, big pharma, and academia. About to hit the stage to discuss our lab's research on how the #GutMicrobiome 💩 is a rich source of health and disease #PrecisionMedicine #Biomarkers. 🧬🔍✨

To Seattle for #BMES2023! ✈️ Chairing the Thurs pm ‘Systems analysis of spatial and microbial cell signaling’ session. Expecting an awesome line-up of talks on single-cell gene networks, human microbiome metabolites, cell signaling, and pathobiont drug targets Biomedical Engineering Society

#BMES2023 is now a wrap! Always proud returning to Biomedical Engineering Society, which has been my academic home for the past 15 years. Great to have caught up with GT and UIUC friends, who are doing terrific innovative work in their own fields Ashlee N. Ford Versypt Josh Hutcheson @HellerLab Caliari Lab

How do we measure if a certain diet is beneficial for YOU? Exploring this in my talk today on our Gut Microbiome Wellness Index 2 at the Food Science and Nutrition Dept. at U MN Twin-Cities. Hoping to brainstorm with colleagues on precision diet methods for a healthier lifestyle.

#ACR2023 American College of Rheumatology is well under way in San Diego! ☀️ Presenting a talk on our giant cell arteritis proteomics research with #MayoClinicRheumatology colleague and friend KenWarringtonMD at the #Vasculitis session Wed 11/15 11am Room 33A-C. If around, please stop by to say hello 😀👋

Identifying GCA diagnosis and disease activity through proteomics from plasma: diagnosis looks good disease activity looks harder (Much like a lot of things in GCA, really) Exciting work Mayo Clinic KenWarringtonMD Jaeyun Sung, PhD #ACR23 ABST2601 Dr. John Cush

At the ☀️Mayo Clinic FL campus to attend the first annual meeting for CLEAR-AD, an NIH U19 consortium to identify #biomarkers and therapeutic targets for #Alzheimers Disease. Wonderful to have Nilufer Ertekin-Taner, MD, PhD lead us off with this morning’s welcoming remarks.

New paper in BMC Medicine: We report #GutMicrobiome results from a phase I clinical trial on the potential of kefir (a fermented dairy drink rich in probiotics) to improve #GutHealth in critically ill patients in the #IntensiveCareUnit (ICU). #ICUResearch bmcmedicine.biomedcentral.com/articles/10.11…

Mayo Clinic in Rochester has once again been named the #1 hospital in the world by Newsweek in their 2024 rankings. Thank you to our exceptional staff who remain committed to our primary value of putting patients’ needs first. bit.ly/4bMahsG #WorldsBestHospitals

Applications now open for CLEAR-AD Diversity Scholars! This 2-yr opportunity for early career scientists seeks to increase representation of African American & Latin American scientists in #Alzheimers research. Scholars will receive$25k/yr. clear-ad.org/index.php/news

Sharing our latest work with KenWarringtonMD in @ARD_BMJ! We used SomaLogic proteomics to identify blood protein patterns in active and inactive Giant Cell Arteritis. Sights are now set to develop and validate ML-based multiplex biomarker panels for GCA!🚀 ard.bmj.com/content/early/…

Our latest tool, the Gut Microbiome Wellness Index2, is now out in Nature Communications. Fantastic work led by Daniel Chang & vinod gupta! GMWI2 is a disease-agnostic indicator of gut health that quantifies disease likelihood from a gut microbiome sample. nature.com/articles/s4146…

Mayo Clinic researchers have developed an innovative computational tool that analyzes the gut microbiome, a complex ecosystem of trillions of bacteria, fungi, viruses and other microorganisms, to provide insights into overall well-being. Learn more: mayocl.in/4e9FLcQ